Literature DB >> 6891504

Cardiac amyloidosis with asymmetrical septal hypertrophy and deterioration after nifedipine.

B E Griffiths, P Hughes, R Dowdle, M R Stephens.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6891504      PMCID: PMC459412          DOI: 10.1136/thx.37.9.711

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  6 in total

1.  Idiopathic hypertrophic subaortic stenosis afflicted: idols of the cave and the marketplace.

Authors:  B H Bulkley
Journal:  Am J Cardiol       Date:  1977-09       Impact factor: 2.778

2.  Nifedipine and beta-blocker drugs.

Authors:  C J Anastassiades
Journal:  Br Med J       Date:  1980-11-08

3.  Improved diastolic function and systolic performance in hypertrophic cardiomyopathy after nifedipine.

Authors:  B H Lorell; W J Paulus; W Grossman; J Wynne; P F Cohn; E Braunwald
Journal:  N Engl J Med       Date:  1980-10-02       Impact factor: 91.245

4.  Pulmonary oedema precipitated by nifedipine.

Authors:  D J Gillmer; P Kark
Journal:  Br Med J       Date:  1980-06-14

5.  M mode echocardiography in hypertrophic cardiomyopathy: diagnostic criteria and prediction of obstruction.

Authors:  Y L Doi; W J McKenna; J Gehrke; C M Oakley; J F Goodwin
Journal:  Am J Cardiol       Date:  1980-01       Impact factor: 2.778

6.  M-mode and two-dimensional echocardiographic features in cardiac amyloidosis.

Authors:  A G Siqueira-Filho; C L Cunha; A J Tajik; J B Seward; T T Schattenberg; E R Giuliani
Journal:  Circulation       Date:  1981-01       Impact factor: 29.690

  6 in total
  10 in total

Review 1.  Transthyretin Cardiac Amyloidosis.

Authors:  Anit K Mankad; Keyur B Shah
Journal:  Curr Cardiol Rep       Date:  2017-08-24       Impact factor: 2.931

2.  Transthyretin Ile 122 and cardiac amyloidosis in African-Americans. 2 case reports.

Authors:  D R Jacobson; M Ittmann; J N Buxbaum; R Wieczorek; P D Gorevic
Journal:  Tex Heart Inst J       Date:  1997

Review 3.  Wild-type transthyretin cardiac amyloidosis (ATTRwt-CA), previously known as senile cardiac amyloidosis: clinical presentation, diagnosis, management and emerging therapies.

Authors:  Ilia G Halatchev; Jingsheng Zheng; Jiafu Ou
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

Review 4.  Natural history and therapy of AL cardiac amyloidosis.

Authors:  Martha Grogan; Angela Dispenzieri
Journal:  Heart Fail Rev       Date:  2015-03       Impact factor: 4.214

Review 5.  Clinical management of amyloid cardiomyopathy.

Authors:  Morris M Kim; Clinton M Kolseth; Dayna Carlson; Ahmad Masri
Journal:  Heart Fail Rev       Date:  2021-09-01       Impact factor: 4.654

6.  Syncope from dynamic left ventricular outflow tract obstruction simulating hypertrophic cardiomyopathy in a patient with primary AL-type amyloid heart disease.

Authors:  José-Luis E Velazquez-Ceceña; David L Lubell; Nagapradeep Nagajothi; Hytham Al-Masri; Mumtaz Siddiqui; Sandeep Khosla
Journal:  Tex Heart Inst J       Date:  2009

Review 7.  Amyloid and the Heart.

Authors:  Aaron M Wolfson; Kevin S Shah; Jignesh K Patel
Journal:  Curr Cardiol Rep       Date:  2019-12-03       Impact factor: 2.931

8.  Features of atrial fibrillation in wild-type transthyretin cardiac amyloidosis: a systematic review and clinical experience.

Authors:  Yuliya Y Mints; Gheorghe Doros; John L Berk; Lawreen H Connors; Frederick L Ruberg
Journal:  ESC Heart Fail       Date:  2018-06-19

Review 9.  Diagnosis and treatment of cardiac amyloidosis: position statement of the German Cardiac Society (DGK).

Authors:  A Yilmaz; J Bauersachs; F Bengel; R Büchel; I Kindermann; K Klingel; F Knebel; B Meder; C Morbach; E Nagel; E Schulze-Bahr; F Aus dem Siepen; N Frey
Journal:  Clin Res Cardiol       Date:  2021-01-18       Impact factor: 5.460

10.  Two Decades of Cardiac Amyloidosis: A Danish Nationwide Study.

Authors:  Oscar Westin; Jawad H Butt; Finn Gustafsson; Morten Schou; Morten Salomo; Lars Køber; Mathew Maurer; Emil L Fosbøl
Journal:  JACC CardioOncol       Date:  2021-08-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.